RankingsPricing
  1. US-listed companies
  2. WEST PHARMACEUTICAL SERVICES INC
  3. Financials
  4. Repurchases of common stock

WEST PHARMACEUTICAL SERVICES INCWST

Market cap
$19.7B
P/E ratio
SummaryFinancials
Period EndRepurchases of common stock (Million USD)YoY (%)
Dec 31, 2024561+27.97%
Dec 31, 2023438+116.12%
Dec 31, 2022203+47.92%
Dec 31, 2021137+18.70%
Dec 31, 2020116+38.99%
Dec 31, 201983+17.37%
Dec 31, 201871-4.84%
Dec 31, 201774+42.53%
Dec 31, 201652+1010.64%
Dec 31, 20125+123.81%
Dec 31, 20102

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)